- $1.19bn
- $624.96m
- $91.37m
- 58
- 28
- 64
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.814 | 0.853 | 201 | 53.9 | 91.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 86.5 | 114 | 129 | 185 | 282 |
Operating Profit | -85.7 | -113 | 72 | -132 | -191 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -77.3 | -111 | 71.9 | -126 | -160 |
Provision for Income Taxes | |||||
Net Income After Taxes | -77.7 | -111 | 67 | -117 | -147 |
Net Income Before Extraordinary Items | |||||
Net Income | -77.7 | -111 | 67 | -117 | -147 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -77.7 | -111 | 67 | -117 | -147 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.95 | -2.78 | 1.38 | -2.47 | -2.76 |